NCT01196390 · BASELINE

Baseline characteristics

Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer · Source last updated 2026-06-02

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms

counts
group Id
BG000
value
98
group Id
BG001
value
96
group Id
BG002
value
194
units
Participants

groups

description
Radiation therapy with concurrent trastuzumab, paclitaxel, and carboplatin followed by surgery followed by maintenance trastuzumab
id
BG000
title
Chemoradiation and Trastuzumab
description
Radiation therapy with concurrent paclitaxel and carboplatin followed by surgery
id
BG001
title
Chemoradiation
description
Total of all reporting groups
id
BG002
title
Total

measures

classes
categories
measurements
group Id
BG000
value
0
group Id
BG001
value
5
group Id
BG002
value
5
title
≤ 39 years
measurements
group Id
BG000
value
6
group Id
BG001
value
7
group Id
BG002
value
13
title
40-49 years
measurements
group Id
BG000
value
30
group Id
BG001
value
21
group Id
BG002
value
51
title
50-59 years
measurements
group Id
BG000
value
40
group Id
BG001
value
31
group Id
BG002
value
71
title
60-69 years
measurements
group Id
BG000
value
20
group Id
BG001
value
29
group Id
BG002
value
49
title
70-79 years
measurements
group Id
BG000
value
2
group Id
BG001
value
3
group Id
BG002
value
5
title
≥ 80 years
param Type
COUNT_OF_PARTICIPANTS
title
Age, Customized
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
13
group Id
BG001
value
17
group Id
BG002
value
30
title
Female
measurements
group Id
BG000
value
85
group Id
BG001
value
79
group Id
BG002
value
164
title
Male
param Type
COUNT_OF_PARTICIPANTS
title
Sex: Female, Male
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
1
group Id
BG001
value
5
group Id
BG002
value
6
title
Hispanic or Latino
measurements
group Id
BG000
value
96
group Id
BG001
value
89
group Id
BG002
value
185
title
Not Hispanic or Latino
measurements
group Id
BG000
value
1
group Id
BG001
value
2
group Id
BG002
value
3
title
Unknown or Not Reported
param Type
COUNT_OF_PARTICIPANTS
title
Ethnicity (NIH/OMB)
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
0
group Id
BG001
value
2
group Id
BG002
value
2
title
American Indian or Alaska Native
measurements
group Id
BG000
value
3
group Id
BG001
value
0
group Id
BG002
value
3
title
Asian
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
Native Hawaiian or Other Pacific Islander
measurements
group Id
BG000
value
1
group Id
BG001
value
0
group Id
BG002
value
1
title
Black or African American
measurements
group Id
BG000
value
94
group Id
BG001
value
92
group Id
BG002
value
186
title
White
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
More than one race
measurements
group Id
BG000
value
0
group Id
BG001
value
2
group Id
BG002
value
2
title
Unknown or Not Reported
param Type
COUNT_OF_PARTICIPANTS
title
Race (NIH/OMB)
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
62
group Id
BG001
value
62
group Id
BG002
value
124
title
0
measurements
group Id
BG000
value
34
group Id
BG001
value
31
group Id
BG002
value
65
title
1
measurements
group Id
BG000
value
2
group Id
BG001
value
3
group Id
BG002
value
5
title
2
description
0 - Asymptomatic; 1 - Symptomatic but completely ambulatory; 2 - Symptomatic, \<50% in bed during the day; 3 - Symptomatic, \>50% in bed, but not bedbound; 4 - Bedbound; 5 - Death
param Type
COUNT_OF_PARTICIPANTS
title
Zubrod Performance Status
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
1
group Id
BG001
value
4
group Id
BG002
value
5
title
T1
measurements
group Id
BG000
value
18
group Id
BG001
value
17
group Id
BG002
value
35
title
T2
measurements
group Id
BG000
value
79
group Id
BG001
value
75
group Id
BG002
value
154
title
T3
description
Tumor stage per the American Joint Committee on Cancer (AJCC) 7th ed. refers to the size and/or extent of the main tumor. The higher the number after the T, the larger the tumor or the more it has grown into nearby tissues.T's may be further divided to provide more detail, such as T3a and T3b.
param Type
COUNT_OF_PARTICIPANTS
title
T stage, clinical
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
27
group Id
BG001
value
29
group Id
BG002
value
56
title
N0
measurements
group Id
BG000
value
55
group Id
BG001
value
48
group Id
BG002
value
103
title
N1
measurements
group Id
BG000
value
16
group Id
BG001
value
19
group Id
BG002
value
35
title
N2
description
Regional lymph nodes staging per American Joint Committee on Cancer (AJCC) 7th ed. refers to the number and/or extent of spread of lymph nodes that contain cancer. The higher the number after the N, the greater the involvement of regional lymph nodes.
param Type
COUNT_OF_PARTICIPANTS
title
N stage, clinical
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
38
group Id
BG001
value
38
group Id
BG002
value
76
title
No
measurements
group Id
BG000
value
48
group Id
BG001
value
48
group Id
BG002
value
96
title
Yes adenopathy, but celiac absent
measurements
group Id
BG000
value
12
group Id
BG001
value
10
group Id
BG002
value
22
title
Yes adenopathy and celiac present ≤ 2 cm
param Type
COUNT_OF_PARTICIPANTS
title
Presence of Adenopathy
unit Of Measure
Participants

population Description

Eligible participants

Complete source fields

denoms

counts
group Id
BG000
value
98
group Id
BG001
value
96
group Id
BG002
value
194
units
Participants

groups

description
Radiation therapy with concurrent trastuzumab, paclitaxel, and carboplatin followed by surgery followed by maintenance trastuzumab
id
BG000
title
Chemoradiation and Trastuzumab
description
Radiation therapy with concurrent paclitaxel and carboplatin followed by surgery
id
BG001
title
Chemoradiation
description
Total of all reporting groups
id
BG002
title
Total

measures

classes
categories
measurements
group Id
BG000
value
0
group Id
BG001
value
5
group Id
BG002
value
5
title
≤ 39 years
measurements
group Id
BG000
value
6
group Id
BG001
value
7
group Id
BG002
value
13
title
40-49 years
measurements
group Id
BG000
value
30
group Id
BG001
value
21
group Id
BG002
value
51
title
50-59 years
measurements
group Id
BG000
value
40
group Id
BG001
value
31
group Id
BG002
value
71
title
60-69 years
measurements
group Id
BG000
value
20
group Id
BG001
value
29
group Id
BG002
value
49
title
70-79 years
measurements
group Id
BG000
value
2
group Id
BG001
value
3
group Id
BG002
value
5
title
≥ 80 years
param Type
COUNT_OF_PARTICIPANTS
title
Age, Customized
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
13
group Id
BG001
value
17
group Id
BG002
value
30
title
Female
measurements
group Id
BG000
value
85
group Id
BG001
value
79
group Id
BG002
value
164
title
Male
param Type
COUNT_OF_PARTICIPANTS
title
Sex: Female, Male
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
1
group Id
BG001
value
5
group Id
BG002
value
6
title
Hispanic or Latino
measurements
group Id
BG000
value
96
group Id
BG001
value
89
group Id
BG002
value
185
title
Not Hispanic or Latino
measurements
group Id
BG000
value
1
group Id
BG001
value
2
group Id
BG002
value
3
title
Unknown or Not Reported
param Type
COUNT_OF_PARTICIPANTS
title
Ethnicity (NIH/OMB)
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
0
group Id
BG001
value
2
group Id
BG002
value
2
title
American Indian or Alaska Native
measurements
group Id
BG000
value
3
group Id
BG001
value
0
group Id
BG002
value
3
title
Asian
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
Native Hawaiian or Other Pacific Islander
measurements
group Id
BG000
value
1
group Id
BG001
value
0
group Id
BG002
value
1
title
Black or African American
measurements
group Id
BG000
value
94
group Id
BG001
value
92
group Id
BG002
value
186
title
White
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
More than one race
measurements
group Id
BG000
value
0
group Id
BG001
value
2
group Id
BG002
value
2
title
Unknown or Not Reported
param Type
COUNT_OF_PARTICIPANTS
title
Race (NIH/OMB)
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
62
group Id
BG001
value
62
group Id
BG002
value
124
title
0
measurements
group Id
BG000
value
34
group Id
BG001
value
31
group Id
BG002
value
65
title
1
measurements
group Id
BG000
value
2
group Id
BG001
value
3
group Id
BG002
value
5
title
2
description
0 - Asymptomatic; 1 - Symptomatic but completely ambulatory; 2 - Symptomatic, \<50% in bed during the day; 3 - Symptomatic, \>50% in bed, but not bedbound; 4 - Bedbound; 5 - Death
param Type
COUNT_OF_PARTICIPANTS
title
Zubrod Performance Status
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
1
group Id
BG001
value
4
group Id
BG002
value
5
title
T1
measurements
group Id
BG000
value
18
group Id
BG001
value
17
group Id
BG002
value
35
title
T2
measurements
group Id
BG000
value
79
group Id
BG001
value
75
group Id
BG002
value
154
title
T3
description
Tumor stage per the American Joint Committee on Cancer (AJCC) 7th ed. refers to the size and/or extent of the main tumor. The higher the number after the T, the larger the tumor or the more it has grown into nearby tissues.T's may be further divided to provide more detail, such as T3a and T3b.
param Type
COUNT_OF_PARTICIPANTS
title
T stage, clinical
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
27
group Id
BG001
value
29
group Id
BG002
value
56
title
N0
measurements
group Id
BG000
value
55
group Id
BG001
value
48
group Id
BG002
value
103
title
N1
measurements
group Id
BG000
value
16
group Id
BG001
value
19
group Id
BG002
value
35
title
N2
description
Regional lymph nodes staging per American Joint Committee on Cancer (AJCC) 7th ed. refers to the number and/or extent of spread of lymph nodes that contain cancer. The higher the number after the N, the greater the involvement of regional lymph nodes.
param Type
COUNT_OF_PARTICIPANTS
title
N stage, clinical
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
38
group Id
BG001
value
38
group Id
BG002
value
76
title
No
measurements
group Id
BG000
value
48
group Id
BG001
value
48
group Id
BG002
value
96
title
Yes adenopathy, but celiac absent
measurements
group Id
BG000
value
12
group Id
BG001
value
10
group Id
BG002
value
22
title
Yes adenopathy and celiac present ≤ 2 cm
param Type
COUNT_OF_PARTICIPANTS
title
Presence of Adenopathy
unit Of Measure
Participants

population Description

Eligible participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice